[1]贾中芝,赵 添,王斯妮,等.钇-90微球放射栓塞治疗肝脏恶性肿瘤患者的术前评估与术后随访——钇-90微球放射栓塞系列回顾（二） [J].介入放射学杂志,2017,(11):1057-1062.
　JIA Zhongzhi,ZHAO Tian,WANG Sini,et al.Series review of radioembolization with yttrium- 90 microspheres（Part Ⅱ）： pre- treatment evaluation and post- treatment follow- up for patients with hepatic malignancy receiving yttrium- 90 microspheres embolization[J].journal interventional radiology,2017,(11):1057-1062.
点击复制

钇-90微球放射栓塞治疗肝脏恶性肿瘤患者的术前评估与术后随访——钇-90微球放射栓塞系列回顾（二）


(/HTML)

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2017年11期
页码:
1057-1062
栏目:
讲座
出版日期:
2017-11-25

文章信息/Info

Title:
Series review of radioembolization with yttrium- 90 microspheres（Part Ⅱ）： pre- treatment evaluation and post- treatment follow- up for patients with hepatic malignancy receiving yttrium- 90 microspheres embolization
作者:
贾中芝;  赵 添;  王斯妮;  郑丽丽;  胡红杰;  王维平
Author(s):
JIA Zhongzhi;  ZHAO Tian;  WANG Sini;  ZHENG Lili;  HU Hongjie;  WANG Weiping
Department of Interventional Radiology， Affiliated Changzhou Municipal No.2 People’s Hospital， Nanjing Medical University， Changzhou， Jiangsu Province 213003， China
关键词:
【关键词】 钇-90;  玻璃微球;  树脂微球;  评估;  随访
文献标志码:
A
摘要:
【摘要】 钇-90（90Y）放射栓塞治疗可以直接将大剂量的放射性物质带到靶肿瘤组织内，是治疗肝脏恶性肿瘤的一种有效方法。与TACE治疗不同，90Y微球放射栓塞术后不良反应的发生率更低，如腹痛、发热、恶性、呕吐。然而，90Y微球放射栓塞治疗的有效性和安全性取决于术前仔细的评估和术后密切的随访。本文将详细讨论肝脏恶性肿瘤患者接受90Y微球放射栓塞治疗前的准备工作和术后随访。

参考文献/References:

［1］ Biederman DM， Titano JJ， Tabori NE， et al. Outcomes of radioembolization in the treatment of hepatocellular carcinoma with portal vein invasion： resin versus glass microspheres［J］. J Vasc Interv Radiol， 2016， 27： 812.e2- 821.e2.
［2］ Padia SA， Lewandowski RJ， Johnson GE， et al. radioembolization of hepatic malignancies： background， quality improvement guidelines， and future directions［J］. J Vasc Interv Radiol， 2017， 28： 1- 15.
［3］ Jia Z， Paz- Fumagalli R， Frey G， et al. Resin- based Yttrium- 90 microspheres for unresectable and failed first- line chemotherapy intrahepatic cholangiocarcinoma： preliminary results［J］. J Cancer Res Clin Oncol， 2017， 143： 481- 489.
［4］ Xing M， Prajapati HJ， Dhanasekaran R， et al. Selective internal Yttrium- 90 radioembolization therapy（90Y- SIRT） versus best supportive care in patients with unresectable metastatic melanoma to the liver refractory to systemic therapy： safety and efficacy cohort study［J］. Am J Clin Oncol， 2017， 40： 27- 34.
［5］ Memon K， Lewandowski RJ， Kulik L， et al. Radioembolization for primary and metastatic liver cancer［J］. Semin Radiat Oncol， 2011， 21： 294- 302.
［6］ Atassi B， Bangash AK， Bahrani A， et al. Multimodality imaging following 90Y radioembolization： a comprehensive review and pictorial essay［J］. Radiographics， 2008， 28： 81- 99.
［7］ Lertpipopmetha K， Tubtawee T， Piratvisuth T， et al. Comparison between computer tomography and magnetic resonance imaging in the diagnosis of small hepatocellular carcinoma［J］. Asian Pac J Cancer Prev， 2016， 17： 4805- 4811.
［8］ Barabasch A， Kraemer NA， Ciritsis A， et al. Diagnostic accuracy of diffusion- weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to 90Y- radioembolization［J］. Invest Radiol， 2015， 50： 409- 415.
［9］ Denecke T， Ruhl R， Hildebrandt B， et al. Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres： evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques［J］. Eur Radiol， 2008， 18： 892- 902.
［10］ Ho S， Lau WY， Leung TW， et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium- 90 microspheres in the treatment of hepatic cancer［J］. Eur J Nucl Med， 1997， 24： 293- 298.
［11］ Salem R， Thurston KG. Radioembolization with 90 yttrium microspheres： a state- of- the- art brachytherapy treatment for primary and secondary liver malignancies. Part 2： special topics［J］. J Vasc Interv Radiol， 2006， 17： 1425- 1439.
［12］ Camacho JC， Moncayo V， Kokabi N， et al. 90Y radioembo- lization： multimodality imaging pattern approach with angiographic correlation for optimized target therapy delivery［J］. Radiographics， 2015， 35： 1602- 1618.
［13］ Kennedy A， Bester L， Salem R， et al. Role of hepatic intra- arterial therapies in metastatic neuroendocrine tumours （NET）： guidelines from the NET- Liver- Metastases Consensus Conference［J］. HPB（Oxford）， 2015， 17： 29- 37.
［14］ Vouche M， Kulik L， Atassi R， et al. Radiological- pathological analysis of WHO， RECIST， EASL， mRECIST and DWI： Imaging analysis from a prospective randomized trial of 90Y ± sorafenib［J］. Hepatology， 2013， 58： 1655- 1666.

相似文献/References:

[1]王斯妮,贾中芝,胡红杰,等.钇-90微球的特性、放射栓塞的操作技术及安全防护——钇-90微球放射栓塞系列回顾（一） [J].介入放射学杂志,2017,(10):952.
　WANG Sini,JIA Zhongzhi,HU Hongjie,et al.Characteristics of yttrium- 90 microsphere， techniques and radiation safety of radioembolization procedure. A series review of radioembolization with yttrium- 90 microspheres（partⅠ）[J].journal interventional radiology,2017,(11):952.
[2]贾中芝,谢双双,郑丽丽,等.钇-90微球的剂量计算——钇-90微球放射栓塞系列回顾（四）[J].介入放射学杂志,2018,27(01):91.
　JIA Zhongzhi,XIE Shuangshuang,ZHENG Lili,et al.Series review of radioembolization with yttrium- 90 microspheres（Part Ⅳ）： dose calculation of yttrium- 90 microspheres[J].journal interventional radiology,2018,27(11):91.
[3]郑丽丽,贾中芝,王斯妮,等.钇-90微球放射栓塞治疗肝脏恶性肿瘤的不良反应和并发症——钇-90微球放射栓塞系列回顾（五） [J].介入放射学杂志,2018,27(02):190.
　ZHENG Lili,JIA Zhongzhi,WANG Sini,et al.Side effects and complications of yttrium- 90 radioembolization therapy for hepatic malignancies. A series review of radioembolization with 90Y microspheres（part Ⅴ）[J].journal interventional radiology,2018,27(11):190.
[4]陈 斌,贾中芝,谢双双,等.钇- 90微球放射栓塞与传统经肝动脉灌注化疗栓塞治疗手术不可切除肝细胞性肝癌的系统性评价及荟萃分析 ——钇- 90微球放射栓塞系列回顾（六） [J].介入放射学杂志,2018,27(09):902.
　CHEN Bin,JIA Zhongzhi,XIE Shuangshuang,et al.Yttrium- 90 radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: systematic review and meta- analysis. A series review of radioembolization with yttrium- 90 microspheres（part Ⅵ）[J].journal interventional radiology,2018,27(11):902.
[5]王草叶,郑 扬,胡红杰,等.钇-90微球在治疗不可切除且其它治疗方法失败的肝内胆管细胞癌中的应用——钇-90微球放射栓塞系列回顾（八）[J].介入放射学杂志,2018,27(11):1107.
　WANG Caoye,ZHENG Yang,HU Hongjie,et al.Treatment of unresectable and other treatments failed intrahepatic cholangiocarcinoma with yttrium- 90 radioembolization. A series review of radioembolization with yttrium- 90 microspheres（part Ⅷ）[J].journal interventional radiology,2018,27(11):1107.
[6]贾中芝.C臂CT在钇-90微球放射栓塞治疗肝脏恶性肿瘤中的应用[J].介入放射学杂志,2022,31(04):413.
　JIA Zhongzhi.The application of cone beam CT in performing Yttrium-90 microspheres radioembolization for hepatic malignancies[J].journal interventional radiology,2022,31(11):413.

备注/Memo

备注/Memo:
（收稿日期：２０１7-０3-2０）
（本文编辑：俞瑞纲）
更新日期/Last Update: 2017-11-16